ArticleFrontiers in cardiovascular medicine2026
Magnetocardiography in diagnosis of MINOCA: a case series.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Currently, there is a paucity of accurate, convenient, rapid, and efficient diagnostic approaches for myocardial infarction with non-obstructive coronary arteries (MINOCA) in patients who have undergone coronary angiography (CAG) or coronary computed tomography angiography (CCTA) confirming non-obstructive coronary arteries, particularly when the ECG is normal or non-diagnostic. Given that MINOCA is pathologically characterized by myocardial ischemia and abnormal local electrical activity, magnetocardiography (MCG), which can sensitively detect changes in myocardial depolarization and repolarization current density, may provide a promising diagnostic option. Case summary: This case series includes 2 patients with non-ST-segment elevation myocardial infarction (NSTEMI), both of whom were confirmed to have a subtype: MINOCA, and all underwent MCG. In both cases, serial ECG findings were normal, yet myocardial enzymes were elevated (suggestive of infarction); thus to resolve this diagnostic ambiguity, we assessed infarction-related waveform features by referencing previously observed infarction characteristics and confirmed that even without ECG-detectable infarction, MCG waveforms still exhibit highly prominent infarction-related features. Subsequent cardiac catheterization confirmed no coronary artery stenosis in both patients. In the second case, cardiac magnetic resonance (CMR) further completed the guideline-specified final diagnostic workflow for MINOCA, which retrospectively validated the diagnostic accuracy of MCG. Conclusion: In real-world clinical practice, conventional diagnostic pathways frequently face challenges in the underdiagnosis and suboptimal classification of MINOCA. As a rapid, painless, non-invasive, and radiation-free technique, MCG may serve as a complementary functional assessment tool for patients with suspected MINOCA and elevated myocardial biomarkers. Based on these preliminary case observations, MCG shows potential to identify subtle electrical abnormalities related to myocardial ischemia that are not readily captured by routine examinations. This study provides exploratory evidence supporting the possible additive value of MCG in refining the diagnostic workflow of MINOCA, and warrants further larger-scale investigations to validate its clinical utility, including differentiation from other non-ischemic myocardial injury conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.